BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding D, Lou X, Hua D, Yu W, Li L, Wang J, Gao F, Zhao N, Ren G, Lin B. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet. 2012;8:e1003065. [PMID: 23236287 DOI: 10.1371/journal.pgen.1003065] [Cited by in Crossref: 135] [Cited by in F6Publishing: 148] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Tümen D, Heumann P, Gülow K, Demirci CN, Cosma LS, Müller M, Kandulski A. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines 2022;10. [PMID: 36551958 DOI: 10.3390/biomedicines10123202] [Reference Citation Analysis]
2 Sun X, Feng W, Cui P, Ruan R, Ma W, Han Z, Sun J, Pan Y, Zhu J, Zhong X, Li J, Ma M, Hu R, Lv M, Huang Q, Zhang W, Feng M, Zhuang X, Huang B, Zhou X. Detection and monitoring of HBV-related hepatocellular carcinoma from plasma cfDNA fragmentation profiles. Genomics 2022;114:110502. [PMID: 36220554 DOI: 10.1016/j.ygeno.2022.110502] [Reference Citation Analysis]
3 Li SS, Zhai XH, Liu HL, Liu TZ, Cao TY, Chen DM, Xiao LX, Gan XQ, Cheng K, Hong WJ, Huang Y, Lian YF, Xiao J. Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. Exp Hematol Oncol 2022;11:71. [PMID: 36243813 DOI: 10.1186/s40164-022-00325-7] [Reference Citation Analysis]
4 Su Y, Ding J, Yang F, He C, Xu Y, Zhu X, Zhou H, Li H. The regulatory role of PDE4B in the progression of inflammatory function study. Front Pharmacol 2022;13:982130. [DOI: 10.3389/fphar.2022.982130] [Reference Citation Analysis]
5 Ariumi Y. Hepatitis B virus polymerase restricts LINE-1 mobility. Gene 2022;:146943. [PMID: 36198378 DOI: 10.1016/j.gene.2022.146943] [Reference Citation Analysis]
6 Salpini R, D’anna S, Benedetti L, Piermatteo L, Gill U, Svicher V, Kennedy PTF. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. Front Microbiol 2022;13:972687. [DOI: 10.3389/fmicb.2022.972687] [Reference Citation Analysis]
7 Yu J, Fan Z, Zhou Z, Zhang P, Bai J, Li X, Tang M, Fan N, Wu X, Nie X, Chen X, Ma D, Chen X, Cui L, Xia X, Yang L, Yi X, Li L. TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy. Cancers 2022;14:3382. [DOI: 10.3390/cancers14143382] [Reference Citation Analysis]
8 Liu W, Cao G. Hepatitis B Virus (HBV) - Induced Hepatocarcinogenesis, a Founding Framework of Cancer Evolution and Development (Cancer Evo-Dev). Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach 2022. [DOI: 10.5772/intechopen.99838] [Reference Citation Analysis]
9 Xie R, You M, Wang X, Du S, Wang F, Yang P. Multimodal Studies in Hepatitis B Virus Associated Hepatocellular Carcinoma. Infectious Diseases & Immunity 2022;2:204-209. [DOI: 10.1097/id9.0000000000000052] [Reference Citation Analysis]
10 Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y. LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment. JHC 2022;Volume 9:203-20. [DOI: 10.2147/jhc.s348785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jia D, Zhang R, Shao J, Zhang W, Cai L, Sun W. Exposure to trace levels of metals and fluoroquinolones increases inflammation and tumorigenesis risk of zebrafish embryos. Environmental Science and Ecotechnology 2022. [DOI: 10.1016/j.ese.2022.100162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li X, Luan S, Luo K, Cao B, Chen B, Kong J, Meng X. Comparative transcriptomic analysis of Chinese shrimp Fenneropenaeus chinensis infected with white spot syndrome virus. Aquaculture Reports 2022;22:100986. [DOI: 10.1016/j.aqrep.2021.100986] [Reference Citation Analysis]
13 Bousali M, Karamitros T. Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma. Microorganisms 2022;10:253. [DOI: 10.3390/microorganisms10020253] [Reference Citation Analysis]
14 Mahapatra S, Mohanty S, Mishra R, Prasad P. An overview of cancer and the human microbiome. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.007] [Reference Citation Analysis]
15 Tippani R, Kalam S, Podeti S, Porika M. Telomerase in hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma 2022. [DOI: 10.1016/b978-0-323-98806-3.00019-2] [Reference Citation Analysis]
16 Kaladhar DS, Srinivasan T. Comparative genomics and molecular epidemiology on hepatitis virus–induced hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma 2022. [DOI: 10.1016/b978-0-323-98806-3.00005-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen C, Wang T, Yang M, Song J, Huang M, Bai Y, Su H. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer. Pathol Oncol Res 2021;27:1609879. [PMID: 34720757 DOI: 10.3389/pore.2021.1609879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Cui D, Li W, Jiang D, Wu J, Xie J, Wu Y. Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma. Front Med (Lausanne) 2021;8:754709. [PMID: 34660653 DOI: 10.3389/fmed.2021.754709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Zhuo Z, Rong W, Li H, Li Y, Luo X, Liu Y, Tang X, Zhang L, Su F, Cui H, Xiao F. Long-read sequencing reveals the structural complexity of genomic integration of HBV DNA in hepatocellular carcinoma. NPJ Genom Med 2021;6:84. [PMID: 34642322 DOI: 10.1038/s41525-021-00245-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lin SY, Su YP, Trauger ER, Song BP, Thompson EGC, Hoffman MC, Chang TT, Lin YJ, Kao YL, Cui Y, Hann HW, Park G, Shieh FS, Song W, Su YH. Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected Patients. Hepatol Commun 2021;5:1649-59. [PMID: 34558837 DOI: 10.1002/hep4.1783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Tsuge M. Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection? Viruses 2021;13:1920. [PMID: 34696350 DOI: 10.3390/v13101920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Wang Y, Tong Y, Zhang Z, Zheng R, Huang D, Yang J, Zong H, Tan F, Xie Y, Huang H, Zhang X. ViMIC: a database of human disease-related virus mutations, integration sites and cis-effects. Nucleic Acids Res 2021:gkab779. [PMID: 34500462 DOI: 10.1093/nar/gkab779] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Midorikawa Y, Tatsuno K, Moriyama M. Genome-wide analysis of hepatitis B virus integration in hepatocellular carcinoma: Insights next generation sequencing. Hepatobiliary Surg Nutr 2021;10:548-52. [PMID: 34430541 DOI: 10.21037/hbsn-21-228] [Reference Citation Analysis]
24 Príncipe C, Dionísio de Sousa IJ, Prazeres H, Soares P, Lima RT. LRP1B: A Giant Lost in Cancer Translation. Pharmaceuticals (Basel) 2021;14:836. [PMID: 34577535 DOI: 10.3390/ph14090836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bousali M, Papatheodoridis G, Paraskevis D, Karamitros T. Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. Microorganisms 2021;9:1787. [PMID: 34442866 DOI: 10.3390/microorganisms9081787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
26 Huang CJ, Wang LH, Wang YC. Identification of Therapeutic Targets for the Selective Killing of HBV-Positive Hepatocytes. J Pers Med 2021;11:649. [PMID: 34357116 DOI: 10.3390/jpm11070649] [Reference Citation Analysis]
27 Wu C, Guo X, Li M, Shen J, Fu X, Xie Q, Hou Z, Zhai M, Qiu X, Cui Z, Xie H, Qin P, Weng X, Hu Z, Liang J. DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites. BMC Ecol Evol 2021;21:138. [PMID: 34233610 DOI: 10.1186/s12862-021-01869-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Elpek GO. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World J Clin Cases 2021; 9(19): 4890-4917 [PMID: 34307543 DOI: 10.12998/wjcc.v9.i19.4890] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
29 Kikuchi M, Kobayashi K, Nishida N, Sawai H, Sugiyama M, Mizokami M, Tokunaga K, Nakaya A. Genome-wide copy number variation analysis of hepatitis B infection in a Japanese population. Hum Genome Var 2021;8:22. [PMID: 34103483 DOI: 10.1038/s41439-021-00154-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Lin SY, Zhang A, Lian J, Wang J, Chang TT, Lin YJ, Song W, Su YH. Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma. Cells 2021;10:1294. [PMID: 34071075 DOI: 10.3390/cells10061294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Ariumi Y. Hepatitis B virus polymerase restricts LINE-1 retrotransposition.. [DOI: 10.1101/2021.05.07.443105] [Reference Citation Analysis]
32 Sekiba K, Otsuka M, Koike K. Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver. Semin Liver Dis 2021;41:142-9. [PMID: 33984871 DOI: 10.1055/s-0041-1723033] [Reference Citation Analysis]
33 Xu H, Jia P, Zhao Z. DeepVISP: Deep Learning for Virus Site Integration Prediction and Motif Discovery. Adv Sci (Weinh) 2021;8:2004958. [PMID: 33977077 DOI: 10.1002/advs.202004958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Lin SY, Su Y, Trauger ER, Song BP, Thompson EGC, Hoffman MC, Chang T, Lin Y, Kao Y, Cui Y, Hann H, Park G, Song W, Su Y. Detection of hepatitis B virus-host junction sequences in urine of infected patients.. [DOI: 10.1101/2021.04.28.21254562] [Reference Citation Analysis]
35 Zhang D, Zhang K, Protzer U, Zeng C. HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site. J Clin Transl Hepatol 2021;9:399-408. [PMID: 34221926 DOI: 10.14218/JCTH.2021.00062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Pollicino T, Caminiti G. HBV-Integration Studies in the Clinic: Role in the Natural History of Infection. Viruses 2021;13:368. [PMID: 33652619 DOI: 10.3390/v13030368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
37 Wu C, Guo X, Li M, Fu X, Hou Z, Zhai M, Shen J, Qiu X, Cui Z, Xie H, Qin P, Weng X, Hu Z, Liang J. DeepHBV: A deep learning model to predict hepatitis B virus (HBV) integration sites.. [DOI: 10.1101/2021.01.08.425855] [Reference Citation Analysis]
38 Caruso S, O'Brien DR, Cleary SP, Roberts LR, Zucman-Rossi J. Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity. Hepatology 2021;73 Suppl 1:14-26. [PMID: 32463918 DOI: 10.1002/hep.31394] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 18.5] [Reference Citation Analysis]
39 Sze KM, Ho DW, Chiu YT, Tsui YM, Chan LK, Lee JM, Chok KS, Chan AC, Tang CN, Tang VW, Lo IL, Yau DT, Cheung TT, Ng IO. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma. Hepatology 2021;73:23-40. [PMID: 32170761 DOI: 10.1002/hep.31231] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
40 Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res 2021;149:1-61. [PMID: 33579421 DOI: 10.1016/bs.acr.2020.10.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
41 Lee J, Tsai K, Ou JJ. Mechanisms of Hepatitis B Virus-Induced Hepatocarcinogenesis. In: Wu T, Chang M, Jeang K, editors. Viruses and Human Cancer. Cham: Springer International Publishing; 2021. pp. 47-70. [DOI: 10.1007/978-3-030-57362-1_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Yang M, Yang G, Li F, Ou M, Li C, Chen J, Lin H, Zhang Y, Xue W, Wu Y, Xu Y, Sui W, Dai Y. HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas. Mol Clin Oncol 2020;13:79. [PMID: 33062269 DOI: 10.3892/mco.2020.2149] [Reference Citation Analysis]
43 Zhang H, Dong P, Guo S, Tao C, Chen W, Zhao W, Wang J, Cheung R, Villanueva A, Fan J, Ding H, Schrodi SJ, Zhang D, Zeng C. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing. BMC Med 2020;18:200. [PMID: 32741373 DOI: 10.1186/s12916-020-01667-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
44 Zhao K, Liu A, Xia Y. Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery. The Innovation 2020;1:100034. [DOI: 10.1016/j.xinn.2020.100034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
45 Giannuzzi D, Aresu L. A First NGS Investigation Suggests No Association Between Viruses and Canine Cancers. Front Vet Sci 2020;7:365. [PMID: 32766289 DOI: 10.3389/fvets.2020.00365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
46 Jia L, Gao Y, He Y, Hooper JD, Yang P. HBV induced hepatocellular carcinoma and related potential immunotherapy. Pharmacol Res. 2020;159:104992. [PMID: 32505833 DOI: 10.1016/j.phrs.2020.104992] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
47 Jiang D, Deng J, Dong C, Ma X, Xiao Q, Zhou B, Yang C, Wei L, Conran C, Zheng SL, Ng IO, Yu L, Xu J, Sham PC, Qi X, Hou J, Ji Y, Cao G, Li M. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma. BMC Cancer 2020;20:403. [PMID: 32393195 DOI: 10.1186/s12885-020-06842-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 D’arienzo V, Ferguson J, Giraud G, Chapus F, Harris J, Wing P, Claydon A, Begum S, Zhuang X, Balfe P, Testoni B, Mckeating J, Parish J. The CCCTC-binding factor CTCF represses hepatitis B virus Enhancer I and regulates viral transcription.. [DOI: 10.1101/2020.05.08.085548] [Reference Citation Analysis]
49 Müller M, Bird TG, Nault JC. The landscape of gene mutations in cirrhosis and hepatocellular carcinoma. J Hepatol 2020;72:990-1002. [PMID: 32044402 DOI: 10.1016/j.jhep.2020.01.019] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
50 Ruan P, Dai X, Sun J, He C, Huang C, Zhou R, Chemin I. Integration of hepatitis B virus DNA into p21-activated kinase 3 (PAK3) gene in HepG2.2.15 cells. Virus Genes 2020;56:168-73. [PMID: 31897927 DOI: 10.1007/s11262-019-01725-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
51 Chou LF, Chen CY, Yang WH, Chen CC, Chang JL, Leu YL, Liou MJ, Wang TH. Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression. Biomolecules 2019;10:E20. [PMID: 31877715 DOI: 10.3390/biom10010020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
52 Tatsuno K, Midorikawa Y, Takayama T, Yamamoto S, Nagae G, Moriyama M, Nakagawa H, Koike K, Moriya K, Aburatani H. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection. Clin Cancer Res 2019;25:6217-27. [PMID: 31320595 DOI: 10.1158/1078-0432.CCR-18-4041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
53 Li X, Li X, Yin Z, Jiang M, Tian W, Tang M, Zhou B. Polymorphisms of rs4787050 and rs8045980 are associated with lung cancer risk in northeast Chinese female nonsmokers. Biomark Med 2019;13:1119-28. [PMID: 31512508 DOI: 10.2217/bmm-2018-0482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
54 Minarovits J, Niller HH. Truncated oncoproteins of retroviruses and hepatitis B virus: A lesson in contrasts. Infection, Genetics and Evolution 2019;73:342-57. [DOI: 10.1016/j.meegid.2019.05.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
55 Jin Y, Lee WY, Toh ST, Tennakoon C, Toh HC, Chow PK, Chung AY, Chong SS, Ooi LL, Sung WK, Lee CG. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. J Transl Med 2019;17:273. [PMID: 31429776 DOI: 10.1186/s12967-019-2025-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
56 Chen H, Chong W, Wu Q, Yao Y, Mao M, Wang X. Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades. Front Immunol 2019;10:1113. [PMID: 31164891 DOI: 10.3389/fimmu.2019.01113] [Cited by in Crossref: 72] [Cited by in F6Publishing: 90] [Article Influence: 18.0] [Reference Citation Analysis]
57 Nakayama R, Ueno Y, Ueda K, Honda T. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1. Oncogene 2019;38:4340-51. [PMID: 30770900 DOI: 10.1038/s41388-019-0726-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
58 Honda T, Rahman MA. Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E645. [PMID: 30717368 DOI: 10.3390/ijms20030645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Li CL, Li CY, Lin YY, Ho MC, Chen DS, Chen PJ, Yeh SH. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology 2019;69:498-512. [PMID: 30070724 DOI: 10.1002/hep.30201] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
60 Bayard Q, Meunier L, Peneau C, Renault V, Shinde J, Nault JC, Mami I, Couchy G, Amaddeo G, Tubacher E, Bacq D, Meyer V, La Bella T, Debaillon-Vesque A, Bioulac-Sage P, Seror O, Blanc JF, Calderaro J, Deleuze JF, Imbeaud S, Zucman-Rossi J, Letouzé E. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress. Nat Commun 2018;9:5235. [PMID: 30531861 DOI: 10.1038/s41467-018-07552-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 15.2] [Reference Citation Analysis]
61 Huang W, Skanderup AJ, Lee CG. Advances in genomic hepatocellular carcinoma research. Gigascience. 2018;7. [PMID: 30521023 DOI: 10.1093/gigascience/giy135] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
62 Yang L, Ye S, Zhao X, Ji L, Zhang Y, Zhou P, Sun J, Guan Y, Han Y, Ni C, Hu X, Liu W, Wang H, Zhou B, Huang J. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer. 2018;9:3225-3235. [PMID: 30271481 DOI: 10.7150/jca.26052] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
63 Lee WY, Bachtiar M, Choo CCS, Lee CG. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics. Biol Rev Camb Philos Soc. 2019;94:353-367. [PMID: 30105774 DOI: 10.1111/brv.12457] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
64 Budzinska MA, Shackel NA, Urban S, Tu T. Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion. Emerg Microbes Infect 2018;7:142. [PMID: 30087321 DOI: 10.1038/s41426-018-0145-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
65 Budzinska MA, Shackel NA, Urban S, Tu T. Cellular Genomic Sites of Hepatitis B Virus DNA Integration. Genes (Basel) 2018;9:E365. [PMID: 30037029 DOI: 10.3390/genes9070365] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
66 An P, Xu J, Yu Y, Winkler CA. Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma. Front Genet 2018;9:261. [PMID: 30073017 DOI: 10.3389/fgene.2018.00261] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 14.8] [Reference Citation Analysis]
67 Sekiba K, Otsuka M, Ohno M, Yamagami M, Kishikawa T, Suzuki T, Ishibashi R, Seimiya T, Tanaka E, Koike K. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA. World J Gastroenterol 2018; 24(21): 2261-2268 [PMID: 29881235 DOI: 10.3748/wjg.v24.i21.2261] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
68 Furuta M, Tanaka H, Shiraishi Y, Unida T, Imamura M, Fujimoto A, Fujita M, Sasaki-Oku A, Maejima K, Nakano K, Kawakami Y, Arihiro K, Aikata H, Ueno M, Hayami S, Ariizumi SI, Yamamoto M, Gotoh K, Ohdan H, Yamaue H, Miyano S, Chayama K, Nakagawa H. Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers. Oncotarget 2018;9:25075-88. [PMID: 29861854 DOI: 10.18632/oncotarget.25308] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
69 Tu T, Budzinska MA, Vondran FWR, Shackel NA, Urban S. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles. J Virol 2018;92:e02007-17. [PMID: 29437961 DOI: 10.1128/JVI.02007-17] [Cited by in Crossref: 90] [Cited by in F6Publishing: 98] [Article Influence: 18.0] [Reference Citation Analysis]
70 Yang Y, Lu Q, Shao X, Mo B, Nie X, Liu W, Chen X, Tang Y, Deng Y, Yan J. Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis. J Cancer 2018;9:1989-2002. [PMID: 29896284 DOI: 10.7150/jca.23762] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
71 Freitas N, Lukash T, Gunewardena S, Chappell B, Slagle BL, Gudima SO. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers. J Virol. 2018;92. [PMID: 29491161 DOI: 10.1128/jvi.02221-17] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
72 Xie Y. Hepatitis B Virus-Associated Hepatocellular Carcinoma. Adv Exp Med Biol 2017;1018:11-21. [PMID: 29052129 DOI: 10.1007/978-981-10-5765-6_2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 91] [Article Influence: 15.0] [Reference Citation Analysis]
73 Tang KW, Larsson E. Tumour virology in the era of high-throughput genomics. Philos Trans R Soc Lond B Biol Sci 2017;372:20160265. [PMID: 28893932 DOI: 10.1098/rstb.2016.0265] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
74 Mao R, Liu J, Liu G, Jin S, Xue Q, Ma L, Fu Y, Zhao N, Xing J, Li L, Qiu Y, Lin B. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis. Oncotarget 2017;8:26185-99. [PMID: 28412734 DOI: 10.18632/oncotarget.15428] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
75 Beer AG, Zenzmaier C, Schreinlechner M, Haas J, Dietrich MF, Herz J, Marschang P. Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member. Oncotarget 2016;7:68721-33. [PMID: 27626682 DOI: 10.18632/oncotarget.11897] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
76 Duan M, Hao J, Cui S, Worthley DL, Zhang S, Wang Z, Shi J, Liu L, Wang X, Ke A, Cao Y, Xi R, Zhang X, Zhou J, Fan J, Li C, Gao Q. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing. Cell Res. 2018;28:359-373. [PMID: 29327728 DOI: 10.1038/cr.2018.11] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 14.4] [Reference Citation Analysis]
77 Hornshøj H, Nielsen MM, Sinnott-Armstrong NA, Świtnicki MP, Juul M, Madsen T, Sallari R, Kellis M, Ørntoft T, Hobolth A, Pedersen JS. Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival. NPJ Genom Med 2018;3:1. [PMID: 29354286 DOI: 10.1038/s41525-017-0040-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
78 Wei X, Liu N, Wang XW, Ji J. Genomics Studies in Hepatocellular Carcinoma via Next-Generation Sequencing. Molecular Pathology Library 2018. [DOI: 10.1007/978-3-319-68082-8_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Malhotra S, Freeberg MA, Winans SJ, Taylor J, Beemon KL. A Novel Long Non-Coding RNA in the hTERT Promoter Region Regulates hTERT Expression. Noncoding RNA 2017;4:E1. [PMID: 29657298 DOI: 10.3390/ncrna4010001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
80 Honda T. Potential Links between Hepadnavirus and Bornavirus Sequences in the Host Genome and Cancer. Front Microbiol 2017;8:2537. [PMID: 29312227 DOI: 10.3389/fmicb.2017.02537] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
81 Yoo S, Wang W, Wang Q, Fiel MI, Lee E, Hiotis SP, Zhu J. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med 2017;15:214. [PMID: 29212479 DOI: 10.1186/s12916-017-0973-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
82 Hornshøj H, Nielsen MM, Sinnott-armstrong NA, Świtnicki MP, Juul M, Madsen T, Sallari R, Kellis M, Ørntoft T, Hobolth A, Pedersen JS. Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.. [DOI: 10.1101/182642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
83 Shieh FS, Jongeneel P, Steffen JD, Lin S, Jain S, Song W, Su YH. ChimericSeq: An open-source, user-friendly interface for analyzing NGS data to identify and characterize viral-host chimeric sequences. PLoS One 2017;12:e0182843. [PMID: 28829778 DOI: 10.1371/journal.pone.0182843] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
84 Yang X, Wu L, Lin J, Wang A, Wan X, Wu Y, Robson SC, Sang X, Zhao H. Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue. Int J Cancer 2017;140:1324-30. [PMID: 27943263 DOI: 10.1002/ijc.30547] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
85 Li ZQ, Hu CL, Yu P, Gu XY, Zhang JJ, Li H, Zhang HY, Lv J, Liu YM, Zeng QL, Yan JY, Yu ZJ, Zhang Y. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors. Clin Res Hepatol Gastroenterol 2017;41:311-8. [PMID: 28237828 DOI: 10.1016/j.clinre.2016.11.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
86 Doggett NA, Mukundan H, Lefkowitz EJ, Slezak TR, Chain PS, Morse S, Anderson K, Hodge DR, Pillai S. Culture-Independent Diagnostics for Health Security. Health Secur 2016;14:122-42. [PMID: 27314653 DOI: 10.1089/hs.2015.0074] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
87 Liu Y, Song L, Ni H, Sun L, Jiao W, Chen L, Zhou Q, Shen T, Cui H, Gao T, Li J. ERBB4 acts as a suppressor in the development of hepatocellular carcinoma. Carcinogenesis 2017;38:465-73. [PMID: 28334319 DOI: 10.1093/carcin/bgx017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
88 Chauhan R, Churchill ND, Mulrooney-Cousins PM, Michalak TI. Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma. Oncogenesis. 2017;6:e317. [PMID: 28414318 DOI: 10.1038/oncsis.2017.22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
89 Tu T, Budzinska MA, Shackel NA, Urban S. HBV DNA Integration: Molecular Mechanisms and Clinical Implications. Viruses. 2017;9. [PMID: 28394272 DOI: 10.3390/v9040075] [Cited by in Crossref: 200] [Cited by in F6Publishing: 210] [Article Influence: 33.3] [Reference Citation Analysis]
90 Wang M, Xi D, Ning Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 2017;11:171-180. [PMID: 28097530 DOI: 10.1007/s12072-016-9779-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
91 Tu T, Jilbert AR. Detection of Hepatocyte Clones Containing Integrated Hepatitis B Virus DNA Using Inverse Nested PCR. Methods Mol Biol 2017;1540:97-118. [PMID: 27975311 DOI: 10.1007/978-1-4939-6700-1_9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
92 Ancey PB, Testoni B, Gruffaz M, Cros MP, Durand G, Le Calvez-Kelm F, Durantel D, Herceg Z, Hernandez-Vargas H. Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes. Oncotarget 2015;6:44877-91. [PMID: 26565721 DOI: 10.18632/oncotarget.6270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
93 Liu Y, Zhou Q, He XS, Song LM, Chen L, Jiao WJ, Shen T, Yao S, Wu H, Hu ZB, Gao TM, Li JM. Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection. Oncotarget 2016;7:4981-92. [PMID: 26701850 DOI: 10.18632/oncotarget.6650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
94 Schulze K, Nault JC, Villanueva A. Genetic profiling of hepatocellular carcinoma using next-generation sequencing. J Hepatol 2016;65:1031-42. [PMID: 27262756 DOI: 10.1016/j.jhep.2016.05.035] [Cited by in Crossref: 164] [Cited by in F6Publishing: 175] [Article Influence: 23.4] [Reference Citation Analysis]
95 Zhao LH, Liu X, Yan HX, Li WY, Zeng X, Yang Y, Zhao J, Liu SP, Zhuang XH, Lin C, Qin CJ, Zhao Y, Pan ZY, Huang G, Liu H, Zhang J, Wang RY, Yang Y, Wen W, Lv GS, Zhang HL, Wu H, Huang S, Wang MD, Tang L, Cao HZ, Wang L, Lee TL, Jiang H, Tan YX, Yuan SX, Hou GJ, Tao QF, Xu QG, Zhang XQ, Wu MC, Xu X, Wang J, Yang HM, Zhou WP, Wang HY. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun 2016;7:12992. [PMID: 27703150 DOI: 10.1038/ncomms12992] [Cited by in Crossref: 156] [Cited by in F6Publishing: 174] [Article Influence: 22.3] [Reference Citation Analysis]
96 Ho DW, Lo RC, Chan LK, Ng IO. Molecular Pathogenesis of Hepatocellular Carcinoma. Liver Cancer 2016;5:290-302. [PMID: 27781201 DOI: 10.1159/000449340] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
97 Huang Z, Zhang W, Gao C, Ji B, Chi X, Zheng W, Wang HL. Dysregulation of GTPase IMAP family members in hepatocellular cancer. Mol Med Rep 2016;14:4119-23. [PMID: 27667392 DOI: 10.3892/mmr.2016.5764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
98 Boldt AB, Beltrame MH, Catarino SJ, Meissner CG, Tizzot R, Messias-Reason IJ. A dual role for Mannan-binding lectin-associated serine protease 2 (MASP-2) in HIV infection. Mol Immunol 2016;78:48-56. [PMID: 27588826 DOI: 10.1016/j.molimm.2016.08.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
99 Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, Balabaud C, Calderaro J, Laurent A, Letexier M, Bioulac-Sage P, Calvo F, Zucman-Rossi J. AAV2 and Hepatocellular Carcinoma. Hum Gene Ther 2016;27:211-3. [PMID: 26935016 DOI: 10.1089/hum.2016.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
100 Ariumi Y. Guardian of the Human Genome: Host Defense Mechanisms against LINE-1 Retrotransposition. Front Chem 2016;4:28. [PMID: 27446907 DOI: 10.3389/fchem.2016.00028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
101 Chiu YT, Wong JK, Choi SW, Sze KM, Ho DW, Chan LK, Lee JM, Man K, Cherny S, Yang WL, Wong CM, Sham PC, Ng IO. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma. J Hepatol 2016;64:1256-64. [PMID: 26867494 DOI: 10.1016/j.jhep.2016.02.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
102 Honda T. Links between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular Carcinoma. Front Chem 2016;4:21. [PMID: 27242996 DOI: 10.3389/fchem.2016.00021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
103 Flippot R, Malouf GG, Su X, Khayat D, Spano JP. Oncogenic viruses: Lessons learned using next-generation sequencing technologies. Eur J Cancer 2016;61:61-8. [PMID: 27156225 DOI: 10.1016/j.ejca.2016.03.086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
104 Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84-S101. [PMID: 27084040 DOI: 10.1016/j.jhep.2016.02.021] [Cited by in Crossref: 461] [Cited by in F6Publishing: 477] [Article Influence: 65.9] [Reference Citation Analysis]
105 Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, Zhang CY, Zen K. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol 2016;64:278-91. [PMID: 26409216 DOI: 10.1016/j.jhep.2015.09.013] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 12.1] [Reference Citation Analysis]
106 Luna JM, Michailidis E, Rice CM. Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. J Hepatol 2016;64:257-9. [PMID: 26541590 DOI: 10.1016/j.jhep.2015.10.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
107 Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer. 2015;15:653-667. [PMID: 26493646 DOI: 10.1038/nrc4017] [Cited by in Crossref: 196] [Cited by in F6Publishing: 206] [Article Influence: 28.0] [Reference Citation Analysis]
108 Moyo B, Nicholson SA, Arbuthnot PB. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma. Virus Research 2016;212:103-13. [DOI: 10.1016/j.virusres.2015.07.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
109 Doolittle-Hall JM, Cunningham Glasspoole DL, Seaman WT, Webster-Cyriaque J. Meta-Analysis of DNA Tumor-Viral Integration Site Selection Indicates a Role for Repeats, Gene Expression and Epigenetics. Cancers (Basel) 2015;7:2217-35. [PMID: 26569308 DOI: 10.3390/cancers7040887] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
110 Piciocchi M, Cardin R, Cillo U, Vitale A, Cappon A, Mescoli C, Guido M, Rugge M, Burra P, Floreani A, Farinati F. Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. Transl Res 2016;168:122-33. [PMID: 26408804 DOI: 10.1016/j.trsl.2015.08.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
111 Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, Balabaud C, Calderaro J, Laurent A, Letexier M, Bioulac-Sage P, Calvo F, Zucman-Rossi J. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 2015;47:1187-93. [PMID: 26301494 DOI: 10.1038/ng.3389] [Cited by in Crossref: 315] [Cited by in F6Publishing: 322] [Article Influence: 39.4] [Reference Citation Analysis]
112 Cao W, Peppelenbosch MP, Pan Q. Virus-host interactions in HBV-related hepatocellular carcinoma: more to be revealed? Gut 2015;64:852-3. [PMID: 25200746 DOI: 10.1136/gutjnl-2014-308283] [Reference Citation Analysis]
113 Tian Y, Ou JH. Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma. Virol Sin 2015;30:85-91. [PMID: 25862579 DOI: 10.1007/s12250-015-3582-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
114 Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479-480:672-686. [PMID: 25759099 DOI: 10.1016/j.virol.2015.02.031] [Cited by in Crossref: 490] [Cited by in F6Publishing: 521] [Article Influence: 61.3] [Reference Citation Analysis]
115 Babaei S, Akhtar W, de Jong J, Reinders M, de Ridder J. 3D hotspots of recurrent retroviral insertions reveal long-range interactions with cancer genes. Nat Commun 2015;6:6381. [PMID: 25721899 DOI: 10.1038/ncomms7381] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
116 Ringelhan M, O'Connor T, Protzer U, Heikenwalder M. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J Pathol. 2015;235:355-367. [PMID: 25196558 DOI: 10.1002/path.4434] [Cited by in Crossref: 83] [Cited by in F6Publishing: 91] [Article Influence: 10.4] [Reference Citation Analysis]
117 Watanabe Y, Yamamoto H, Oikawa R, Toyota M, Yamamoto M, Kokudo N, Tanaka S, Arii S, Yotsuyanagi H, Koike K, Itoh F. DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences. Genome Res 2015;25:328-37. [PMID: 25653310 DOI: 10.1101/gr.175240.114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
118 Ji X, Zhang Q, Du Y, Liu W, Li Z, Hou X, Cao G. Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma. Curr Genomics. 2014;15:469-480. [PMID: 25646075 DOI: 10.2174/1389202915666141114213833] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
119 Ozkal-Baydin P. How did hepatitis B virus effect the host genome in the last decade? World J Hepatol 2014; 6(12): 851-859 [PMID: 25544872 DOI: 10.4254/wjh.v6.i12.851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
120 Shiraishi Y, Fujimoto A, Furuta M, Tanaka H, Chiba K, Boroevich KA, Abe T, Kawakami Y, Ueno M, Gotoh K, Ariizumi S, Shibuya T, Nakano K, Sasaki A, Maejima K, Kitada R, Hayami S, Shigekawa Y, Marubashi S, Yamada T, Kubo M, Ishikawa O, Aikata H, Arihiro K, Ohdan H, Yamamoto M, Yamaue H, Chayama K, Tsunoda T, Miyano S, Nakagawa H. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers. PLoS One 2014;9:e114263. [PMID: 25526364 DOI: 10.1371/journal.pone.0114263] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
121 Zou S, Li J, Zhou H, Frech C, Jiang X, Chu JS, Zhao X, Li Y, Li Q, Wang H. Mutational landscape of intrahepatic cholangiocarcinoma. Nat Commun. 2014;5:5696. [PMID: 25526346 DOI: 10.1038/ncomms6696] [Cited by in Crossref: 221] [Cited by in F6Publishing: 306] [Article Influence: 24.6] [Reference Citation Analysis]
122 Heikenwalder M, Protzer U. LINE(1)s of evidence in HBV-driven liver cancer. Cell Host Microbe 2014;15:249-50. [PMID: 24629329 DOI: 10.1016/j.chom.2014.02.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
123 Datta S, Chatterjee S, Veer V. Recent advances in molecular diagnostics of hepatitis B virus. World J Gastroenterol 2014; 20(40): 14615-14625 [PMID: 25356025 DOI: 10.3748/wjg.v20.i40.14615] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
124 Katz JP, Pipas JM. SummonChimera infers integrated viral genomes with nucleotide precision from NGS data. BMC Bioinformatics 2014;15:348. [PMID: 25331652 DOI: 10.1186/s12859-014-0348-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
125 Horpaopan S, Spier I, Zink AM, Altmüller J, Holzapfel S, Laner A, Vogt S, Uhlhaas S, Heilmann S, Stienen D, Pasternack SM, Keppler K, Adam R, Kayser K, Moebus S, Draaken M, Degenhardt F, Engels H, Hofmann A, Nöthen MM, Steinke V, Perez-Bouza A, Herms S, Holinski-Feder E, Fröhlich H, Thiele H, Hoffmann P, Aretz S. Genome-wide CNV analysis in 221 unrelated patients and targeted high-throughput sequencing reveal novel causative candidate genes for colorectal adenomatous polyposis. Int J Cancer 2015;136:E578-89. [PMID: 25219767 DOI: 10.1002/ijc.29215] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
126 Tarocchi M, Polvani S, Marroncini G, Galli A. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 2014; 20(33): 11630-11640 [PMID: 25206269 DOI: 10.3748/wjg.v20.i33.11630] [Cited by in CrossRef: 123] [Cited by in F6Publishing: 124] [Article Influence: 13.7] [Reference Citation Analysis]
127 Su YH, Lin SY, Song W, Jain S. DNA markers in molecular diagnostics for hepatocellular carcinoma. Expert Rev Mol Diagn. 2014;14:803-817. [PMID: 25098554 DOI: 10.1586/14737159.2014.946908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
128 Datta S, Roychoudhury S, Ghosh A, Dasgupta D, Ghosh A, Chakraborty BC, Ray S, Gupta S, Santra AK, Datta S. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients. PLoS One. 2014;9:e102573. [PMID: 25032957 DOI: 10.1371/journal.pone.0102573] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
129 Honeycutt J, Hammam O, Fu CL, Hsieh MH. Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer. Trends Parasitol 2014;30:324-32. [PMID: 24913983 DOI: 10.1016/j.pt.2014.05.004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
130 Moens U, Van Ghelue M, Ehlers B. Are human polyomaviruses co-factors for cancers induced by other oncoviruses? Rev Med Virol. 2014;24:343-360. [PMID: 24888895 DOI: 10.1002/rmv.1798] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
131 Carulli L, Anzivino C. Telomere and telomerase in chronic liver disease and hepatocarcinoma. World J Gastroenterol 2014; 20(20): 6287-6292 [PMID: 24876749 DOI: 10.3748/wjg.v20.i20.6287] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
132 Chen YL, Jeng YM, Chang CN, Lee HJ, Hsu HC, Lai PL, Yuan RH. TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection. Int J Surg. 2014;12:659-665. [PMID: 24866078 DOI: 10.1016/j.ijsu.2014.05.066] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
133 Li X, Zhang J, Yang Z, Kang J, Jiang S, Zhang T, Chen T, Li M, Lv Q, Chen X, McCrae MA, Zhuang H, Lu F. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma. J Hepatol 2014;60:975-84. [PMID: 24362074 DOI: 10.1016/j.jhep.2013.12.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 7.7] [Reference Citation Analysis]
134 Steichen C, Luce E, Maluenda J, Tosca L, Moreno-Gimeno I, Desterke C, Dianat N, Goulinet-Mainot S, Awan-Toor S, Burks D, Marie J, Weber A, Tachdjian G, Melki J, Dubart-Kupperschmitt A. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: Analysis of genomic integrity. Stem Cells Transl Med. 2014;3:686-691. [PMID: 24736403 DOI: 10.5966/sctm.2013-0158] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
135 Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, Tong JH, Lai PB, Chan HL, To KF, Chan TF, Wong N. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell. 2014;25:335-349. [PMID: 24582836 DOI: 10.1016/j.ccr.2014.01.030] [Cited by in Crossref: 204] [Cited by in F6Publishing: 216] [Article Influence: 22.7] [Reference Citation Analysis]
136 Serrao E, Krishnan L, Shun MC, Li X, Cherepanov P, Engelman A, Maertens GN. Integrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding. Nucleic Acids Res. 2014;42:5164-5176. [PMID: 24520116 DOI: 10.1093/nar/gku136] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
137 Higgs MR, Chouteau P, Lerat H. ‘Liver let die’: oxidative DNA damage and hepatotropic viruses. J Gen Virol. 2014;95:991-1004. [PMID: 24496828 DOI: 10.1099/vir.0.059485-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
138 Gao G, Kasperbauer JL, Tombers NM, Wang V, Mayer K, Smith DI. A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas: Large Common Fragile Sites Genes and Oropharyngeal Squamous Cell Carcinoma. Genes Chromosomes Cancer 2014;53:392-401. [DOI: 10.1002/gcc.22150] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
139 Zhao LL, Zhang T, Liu BR, Liu TF, Tao N, Zhuang LW. Construction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level. Mol Biol Rep 2014;41:2875-83. [PMID: 24469724 DOI: 10.1007/s11033-014-3143-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
140 Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 2014;26:78-88. [PMID: 24457013 DOI: 10.1016/j.semcancer.2014.01.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 12.3] [Reference Citation Analysis]
141 Rodriguez-Frias F, Buti M, Tabernero D, Homs M. Quasispecies structure, cornerstone of hepatitis B virus infection: Mass sequencing approach. World J Gastroenterol 2013; 19(41): 6995-7023 [PMID: 24222943 DOI: 10.3748/wjg.v19.i41.6995] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
142 Bloom K, Ely A, Mussolino C, Cathomen T, Arbuthnot P. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 2013;21:1889-97. [PMID: 23883864 DOI: 10.1038/mt.2013.170] [Cited by in Crossref: 151] [Cited by in F6Publishing: 160] [Article Influence: 15.1] [Reference Citation Analysis]
143 Mukherjee RM, Shravanti GV, Jakkampudi A, Kota R, Jangala AL, Reddy PB, Rao PN, Gupta R, Reddy DN. Reduced Expression of DNA Damage Repair Genes High Mobility Group Box1 and Poly(ADP-ribose) Polymerase1 in Inactive Carriers of Hepatitis B Virus Infection-A Possible Stage of Viral Integration. J Clin Exp Hepatol 2013;3:89-95. [PMID: 25755481 DOI: 10.1016/j.jceh.2013.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
144 Wang Q, Jia P, Zhao Z. VirusFinder: software for efficient and accurate detection of viruses and their integration sites in host genomes through next generation sequencing data. PLoS One 2013;8:e64465. [PMID: 23717618 DOI: 10.1371/journal.pone.0064465] [Cited by in Crossref: 109] [Cited by in F6Publishing: 115] [Article Influence: 10.9] [Reference Citation Analysis]
145 Korcsmaros T, Dunai ZA, Vellai T, Csermely P. Teaching the bioinformatics of signaling networks: an integrated approach to facilitate multi-disciplinary learning. Brief Bioinform 2013;14:618-32. [PMID: 23640570 DOI: 10.1093/bib/bbt024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
146 Tretyakov K, Goldberg T, Jin VX, Horton P. Summary of talks and papers at ISCB-Asia/SCCG 2012. BMC Genomics 2013;14:I1. [DOI: 10.1186/1471-2164-14-s2-i1] [Reference Citation Analysis]